Chief Legal Officer & Secretary · C4 Therapeutics, Inc. (CCCC)

Jolie Siegel

FY2021 is the first fiscal year CompBrief holds for Jolie Siegel as a named executive officer of C4 Therapeutics; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$3,375,441

Salary $414,000Stock awards $0

4th of 6 named executive officers at C4 Therapeutics by FY2021 total.

6 named officers on file for C4 Therapeutics, FY2021

Jolie Siegel’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 1 equity grant, each cited to its filing
  • CCCC’s disclosed peer group of 20 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how C4 Therapeutics’s whole pay program stands against its peers

  • C4 Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on CCCC→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 29, 2022 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Jolie Siegel’s full pay file as a PDF — free

More than this page: up to 10 years of Jolie’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Jolie Siegel compensation by year

C4 Therapeutics Summary Compensation Table · the one fiscal year held
In US dollars, as C4 Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021
Salary$414,000
Bonus$0
Stock awards$0
Option awards$2,765,041
Non-equity incentive$190,400
Pension and deferred compensation$0
All other$6,000
Total$3,375,441

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: C4 Therapeutics, Inc. DEF 14A filed April 29, 2022, accession 0001193125-22-130938, and prior-year filings. Open the filing on EDGAR.

How this page was built: the C4 Therapeutics, Inc. filed document, accession 0001193125-22-130938. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2022.

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
Option222,241—$4.98
Option68,941—$45.54

Per the Outstanding Equity Awards at Fiscal Year-End table in C4 Therapeutics, Inc.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

26 Form 4 lines since the FY2021 proxy (filed April 29, 2022)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2025-02-14Tax withholding—2,914$3.18107,939
2025-02-14Grant or award derivative—84,700$0.0084,700
2025-02-14Grant or award—56,500$0.00110,853
2025-02-13Tax withholding—2,135$3.2054,353
2024-11-07Exercise or conversion—3,750—57,590
2024-11-07Tax withholding—1,102$6.0456,488
2024-11-07Exercise or conversion derivative—3,750$0.0010,500
2024-09-16Exercise or conversion—2,250—54,501

The 8 most recent of 26 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

C4 Therapeutics’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Lauren WhiteChief Financial Officer$4,085,603
Stewart FisherChief Scientific Officer$3,788,874
Adam CrystalChief Medical Officer$3,564,503
Jolie Siegel · this pageChief Legal Officer & Secretary$3,375,441
Andrew HirschPresident & Chief Executive Officer$952,200
William McKeeFormer Chief Financial Officer$348,403

The full C4 Therapeutics compensation record

free company brief

This page is one person within C4 Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the C4 Therapeutics proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are C4 Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Jolie Siegel's compensation dossier · One-time report. No refunds.